hepatocellular carcinoma
Conditions
Interventions
1-BCLC B:DEB-TACE
1-BCLC C:DEB-TACE
2-BCLC B:C-TACE
2-BCLC C:C-TACE
Sponsors
the Third Affiliated Hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Clinical or pathological diagnosis of hepatocellular carcinoma; 2. The maximum diameter of the tumors are less than 10cm, diagnosis of BCLC stage B or C; 3. Child-Pugh level A or B, ECOG performance status of 0-2; 4. Be able to follow the visit/treatment rules according to the research programs.
Exclusion criteria
Exclusion criteria: 1. Extrahepatic metastasis; 2. Tumor thrombis invase main portal vein; 3. Patients with previously/future surgery, local-regional therapies (radiofrequency ablation, et al), or liver transplantation; 4. Patients with previously/future sorafenib therapy, systemic chemotherapy, intra-arterial chemoinfusion; 5. Had other serious medical comorbidities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oversurvival;Time to progression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Life Quality; | — |
Countries
China
Contacts
Public ContactMingsheng Huang, Hong Shan
Outcome results
None listed